Trial site
Suita
- 19running trials
- 8closed trials
The trials here
What the 27 trials at this site are about, from their registry records.
- Conditions
- Chronic myeloid leukaemia5 trials
- Childhood cancers4 trials
- High blood pressure4 trials
- Multiple sclerosis2 trials
- Myasthenia gravis2 trials
- Acute lymphoblastic leukaemia1 trial
- Acute myeloid leukaemia1 trial
- ANCA-associated vasculitis1 trial
- Dermatomyositis and polymyositis (myositis)1 trial
- Diabetic eye disease1 trial
- Diffuse large B-cell lymphoma1 trial
- Epilepsy1 trial
- and 8 more
- Phase
- Phase 311 trials
- Phase 28 trials
- Phase 41 trial
- Status
- Active, not recruiting16 trials
- Completed8 trials
- Recruiting3 trials
- Lead sponsor
- Novartis Pharmaceuticals27 trials
Running trials
Recruiting
An Open-label Extension Safety and Efficacy Study of QCZ484 in Hypertensive Patients.
Recruiting
Active, not recruiting
A Study to Identify an Optimal Dose of QCZ484 in Mild to Moderate Hypertensive Patients
Active, not recruiting
Phase 2 Study Evaluating Rapcabtagene Autoleucel in Participants With Severe Active GPA or MPA
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
A Study of Oral Asciminib Versus Other TKIs in Adult Patients With Newly Diagnosed Ph+ CML-CP
Active, not recruiting
Long-term Safety and Tolerability of Iptacopan in Patients With Paroxysmal Nocturnal Hemoglobinuria
Active, not recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Childhood cancers2 recruiting
- Acute lymphoblastic leukaemia1 recruiting
- Diffuse large B-cell lymphoma1 recruiting
- High blood pressure1 recruiting
Closed trials
Completed
Completed
Special Drug Use Surveillance of Entresto Tablets (Hypertension)
Completed
Special Drug Use Observational Study With Beovu Kit for Intravitreal Injection
Completed
Completed
Completed
Special Drug-use Surveillance for Kesimpta for s.c. Injection 20 mg Pen
Completed
Completed
Nilotinib Treatment-free Remission Study in CML (Chronic Myeloid Leukemia) Patients
Site data: ClinicalTrials.govUpdated 13 Nov 2026